Company Valuation: AB Science

Data adjusted to current consolidation scope
Fiscal Period: December 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 332.2 180.9 57.55 112 56.41 - -
Change - -45.55% -68.19% 94.7% -49.65% - -
Enterprise Value (EV) 332.2 180.9 57.55 112 56.41 56.41 56.41
Change - -45.55% -68.19% 94.7% -49.65% 0% 0%
P/E -24.4x -17.8x -5.88x - - - -
PBR - - - - - - -
PEG - 0.6x 0.2x - - - -
Capitalization / Revenue - 187x 53.7x 95.4x 47x 43.4x 35.3x
EV / Revenue - 0x 0x 0x 47x 43.4x 35.3x
EV / EBITDA - - - - - - -
EV / EBIT - -0x -0x 0x -8.68x -8.81x -
EV / FCF - -0x - -0x -8.81x -15.7x -14.5x
FCF Yield - -9.52% - -4.08% -11.3% -6.38% -6.91%
Dividend per Share 2 - - - - - - -
Rate of return - - - - - - -
EPS 2 -0.29 -0.2 -0.15 - - - -
Distribution rate - - - - - - -
Net sales 1 - 0.97 1.072 1.174 1.2 1.3 1.6
EBITDA - -11.16 -5.416 - - - -
EBIT 1 - -13.43 -6.083 0.639 -6.5 -6.4 -
Net income -13.62 -10.05 -7.831 - - - -
Net Debt - - - - - - -
Reference price 2 7.0900 3.5550 0.8820 1.5360 0.7050 0.7050 0.7050
Nbr of stocks (in thousands) 46,861 50,891 65,248 72,947 80,015 - -
Announcement Date 01/03/23 15/05/24 13/05/25 13/05/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
106.85x5.96x25.29x2.32% 362B
21.99x2.99x10.44x1.81% 64.74B
15.6x7.61x11.67x - 12.76B
14.4x1.79x6.09x3.08% 7.53B
18.45x5.72x15.24x-.--% 4.38B
36.39x2.38x27.07x0.76% 4.08B
33.97x5.33x15.59x - 2.96B
-210x - - -.--% 2.44B
Average 4.71x 4.54x 15.91x 1.33% 57.66B
Weighted average by Cap. 87.30x 5.48x 22.36x 2.21%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!